| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/16/1997 | EP0506666B1 Method for the production of catalytic rna in bacteria |
| 07/16/1997 | EP0459978B1 Class i mhc modulation of surface receptor activity |
| 07/16/1997 | EP0452391B1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 07/16/1997 | CN1154705A Organic compound |
| 07/16/1997 | CN1154704A New peptides with immunomodulatory effect |
| 07/16/1997 | CN1154653A Controlled release of metal cation-stabilized interferon |
| 07/16/1997 | CN1154652A Desquamation compositions |
| 07/16/1997 | CN1154371A Gonadotropins with non-native disulfide bridges |
| 07/15/1997 | US5648511 Method for making intermediates useful in the synthesis of retroviral protease inhibitors |
| 07/15/1997 | US5648497 Retroviral protease inhibiting compounds |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648472 Process for preparing virus-inactivated immunoglobulin solutions |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648465 Cloning and expression of neurocan, a chondroitin sulfate proteoglycan |
| 07/15/1997 | US5648464 Human Notch and Delta binding domains in toporythmic proteins, and methods based thereon |
| 07/15/1997 | US5648461 Antitumor |
| 07/15/1997 | US5648458 Peptides and compounds that bind to ELAM-1 |
| 07/15/1997 | US5648456 Reductive cleavage with borohydride |
| 07/15/1997 | US5648455 Treatment of drug resistant bacteria |
| 07/15/1997 | US5648397 Antibiotic, antihistamine, topical |
| 07/15/1997 | US5648393 Treatment of male impotence with s-nitrosylated compounds |
| 07/15/1997 | US5648364 Heterocyclic peptide compounds as enzyme inhibitors |
| 07/15/1997 | US5648355 Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 07/15/1997 | US5648340 Antitumor |
| 07/15/1997 | US5648339 Herpoxin: herpes virus inhibitor and method |
| 07/15/1997 | US5648338 Inhibitors and substrates of thrombin |
| 07/15/1997 | US5648337 Antiherpes pentapeptides |
| 07/15/1997 | US5648336 Bradykinin antagonist peptides containing indane-substituted amino acids |
| 07/15/1997 | US5648335 Prevention and treatment of peripheral neuropathy |
| 07/15/1997 | US5648334 Methods of treatment using ciliary neurotrophic factor |
| 07/15/1997 | US5648333 Peptides having bradykinin antagonist action |
| 07/15/1997 | US5648332 Method of treating diabetes mellitus using variable α domain of T-cell receptor |
| 07/15/1997 | US5648331 Tissue factor pathway inhibitor |
| 07/15/1997 | US5648330 Method and composition for treating vascular graft occlusion |
| 07/15/1997 | US5648273 Hepatic growth factor receptor is the MET proto-oncogene |
| 07/15/1997 | US5648265 Apparatus for preparing fibrinogen adhesive from whole blood |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648253 Inhibitor-resistant urokinase |
| 07/15/1997 | US5648250 Tissue plasminogen activator |
| 07/15/1997 | US5648242 Method of production of birch pollen allergen P14 |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648234 Biosynthesis |
| 07/15/1997 | US5648233 Annticarcinogenic agents and antitumor agents |
| 07/15/1997 | US5648226 Isolated peptides derived from tumor rejection antigens, and their use |
| 07/15/1997 | US5648217 DNA sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof |
| 07/15/1997 | US5648215 Telomerase diagnostic methods |
| 07/15/1997 | US5648214 High-affinity oligonucleotide ligands to the tachykinin substance P |
| 07/15/1997 | US5648100 Acrylamide polymers |
| 07/15/1997 | US5648078 Monoclonal antibodies |
| 07/15/1997 | US5648077 Monoclonal antibodies and binding to hepatitis b and antigens |
| 07/15/1997 | US5648076 Administering antigrowth factor antibodies following surgery |
| 07/15/1997 | US5648075 Iodine based germicidal composition |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |
| 07/15/1997 | US5648071 Method of treating tumors |
| 07/15/1997 | US5648059 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 07/15/1997 | US5647957 Recycling |
| 07/15/1997 | CA2063400C Inhibition of the n-end rule pathway in living cells |
| 07/10/1997 | WO1997024619A1 Novel method of diagnosing and treating gliomas |
| 07/10/1997 | WO1997024572A1 Ceramic packing with channels for thermal and catalytic beds |
| 07/10/1997 | WO1997024453A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | WO1997024446A2 Gene delivery vehicle-targeting ligands |
| 07/10/1997 | WO1997024445A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024439A1 Gene which enables cancer cells to return to normal |
| 07/10/1997 | WO1997024436A2 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
| 07/10/1997 | WO1997024373A1 Monoclonal antibody antagonists to haemopoietic growth factors |
| 07/10/1997 | WO1997024371A1 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
| 07/10/1997 | WO1997024370A1 Novel antigenic proteins of mycoplasmata, genes thereof, and recombinant vector and use of the same |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024366A1 Sodium pump inhibitor compounds and their binding partners |
| 07/10/1997 | WO1997024339A1 Tetrazole derivatives and drugs containing the same as the active ingredient |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024139A1 Peanut allergens and methods |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024136A1 Immunologically active mistletoe extract preparations |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024111A2 Novel hyaluronic acid receptors binding agents and the use thereof |
| 07/10/1997 | WO1997017945A3 Methods and compositions for the delivery of monomeric proteins |
| 07/10/1997 | WO1997015662A3 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 07/10/1997 | WO1997011682A3 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/10/1997 | WO1997008309A3 Ribozyme therapy for hepatitis b infections |
| 07/10/1997 | WO1997007769A3 Chemical compounds |
| 07/10/1997 | DE19600480A1 Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen Use of serine proteinases against acne and inflamed comedones |
| 07/10/1997 | DE19544768C1 Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose Using a combination of pentoxifylline with type I interferons for the treatment of multiple sclerosis |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2240292A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/10/1997 | CA2239299A1 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/09/1997 | EP0783037A1 Polypeptides with a dopaminergic receptor (D2-R and D3-R) activity and use of these polypeptides to screen substances having a selective activity on these polypeptides |
| 07/09/1997 | EP0783003A1 Novel polypeptides |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0782859A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| 07/09/1997 | EP0782709A1 Detection and treatment of cancer |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | EP0782622A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) APO(a)] |